Novo Nordisk surges after U.S. regulators approve the first GLP-1 pill, while shares of rival pharma giant Eli Lilly decline.

Bank of America's Vivek Arya sees a 30% surge in chip sales and a $900 billion accelerator market just over the horizon.

This is the fourth in a series of articles in which I'm ranking the best "Magnificent Seven" stocks to buy for 2026, in ...

Here are 10 of CFRA analysts' top growth stocks to buy that have reported at least 15% annual revenue growth in the past ...

Space stocks have rallied in recent weeks following news that Musk's SpaceX is planning to go public next year and widespread ...

Major stock indexes ended higher Wednesday in a shortened session ahead of a Christmas closure, with the Dow Jones Industrial ...

The semiconductor sector is poised for stronger growth in 2026, positioning some of the top names in this sector for solid gains.

REITs are out of favor, offering dividend investors a chance to buy industry leaders while they have attractive yields.

The FTSE 100 (^FTSE) was muted and European stocks were just above the flat line as trading got under way on Wednesday, as ...

The iShares MSCI Spain ETF remains a strong buy for 2026, with robust GDP growth, sector strength, and a 2.28% dividend yield ...

Despite Warren Buffett’s impending departure, these five stocks are likely to stay in the Berkshire Hathaway portfolio for ...

UK shares edged lower and French shares were muted in thin trading, while most major European benchmarks were closed for ...